• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用流式细胞术对发育异常痣和恶性黑色素瘤的增殖指数及倍性进行的比较研究。

A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.

作者信息

Slater S D, Cook M G, Fisher C, Wright N A, Foster C S

机构信息

Department of Histopathology, RPMS, Hammersmith Hospital, London, UK.

出版信息

Histopathology. 1991 Oct;19(4):337-44. doi: 10.1111/j.1365-2559.1991.tb00048.x.

DOI:10.1111/j.1365-2559.1991.tb00048.x
PMID:1937413
Abstract

Cell proliferation indices and DNA content have been determined in 18 intradermal naevi, 40 dysplastic naevi and 16 superficial malignant melanomas (less than 0.76 mm depth of invasion) using flow cytometry. In this study, proliferation indices of intradermal naevi and dysplastic naevi were not significantly different from each other. Abnormalities of DNA ploidy were not identified in the intradermal naevi or dysplastic naevi; whereas three of the malignant melanomas were aneuploid. In addition, cellular proliferation was increased within the group of malignant melanomas, in comparison with the naevi. This study has found no evidence to indicate that sporadic dysplastic naevi were more likely than intradermal naevi to transform to malignant melanoma, when objective criteria were employed. However, dysplastic naevi could be distinguished from some early malignant melanomas by absence of aneuploidy and by low cell proliferation indices.

摘要

使用流式细胞术测定了18例皮内痣、40例发育异常痣和16例浅表恶性黑色素瘤(浸润深度小于0.76mm)的细胞增殖指数和DNA含量。在本研究中,皮内痣和发育异常痣的增殖指数彼此无显著差异。在皮内痣或发育异常痣中未发现DNA倍体异常;而3例恶性黑色素瘤为非整倍体。此外,与痣相比,恶性黑色素瘤组的细胞增殖增加。当采用客观标准时,本研究没有发现证据表明散发性发育异常痣比皮内痣更易转变为恶性黑色素瘤。然而,发育异常痣可通过不存在非整倍体和低细胞增殖指数与一些早期恶性黑色素瘤相区分。

相似文献

1
A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.运用流式细胞术对发育异常痣和恶性黑色素瘤的增殖指数及倍性进行的比较研究。
Histopathology. 1991 Oct;19(4):337-44. doi: 10.1111/j.1365-2559.1991.tb00048.x.
2
Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.利用视频成像技术评估皮肤良性和恶性黑素细胞性病变中的DNA倍体及DNA异常程度。
Cancer. 2000 Mar 15;88(6):1370-7.
3
Diagnostic impact of nuclear DNA content and proliferative activity in benign and malignant melanocytic lesions.核DNA含量及增殖活性在良性和恶性黑素细胞性病变中的诊断意义
Melanoma Res. 1996 Feb;6(1):37-43. doi: 10.1097/00008390-199602000-00006.
4
Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.黑素细胞发育异常痣介于良性黑素细胞痣和皮肤恶性黑色素瘤之间:新出现的线索。
J Clin Pathol. 2005 May;58(5):453-6. doi: 10.1136/jcp.2004.019422.
5
Evaluation of DNA ploidy in dysplastic and Spitz nevi by flow cytometry.通过流式细胞术评估发育异常痣和斯皮茨痣中的DNA倍性。
J Cutan Pathol. 1990 Dec;17(6):342-7. doi: 10.1111/j.1600-0560.1990.tb00110.x.
6
Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.原发性恶性黑色素瘤和痣中DNA异常的意义:一项回顾性流式细胞术研究
Cancer Res. 1986 Jun;46(6):3192-5.
7
Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
Acta Derm Venereol. 1991;71(6):525-8.
8
[Nevus and malignant cutaneous melanoma].[痣与恶性皮肤黑色素瘤]
Rev Sanid Hig Publica (Madr). 1991 May-Jun;65(3):233-8.
9
Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi.恶性黑色素瘤和先天性痣中N-ras癌基因的点突变。
Br J Dermatol. 1994 Jul;131(1):72-7. doi: 10.1111/j.1365-2133.1994.tb08460.x.
10
[Connection between uveal melanoma and dysplastic naevus syndrome].[葡萄膜黑色素瘤与发育异常痣综合征之间的关联]
Magy Onkol. 2005;49(1):15-8. Epub 2005 May 18.

引用本文的文献

1
DNA index and S phase fraction in uveal malignant melanomas.葡萄膜恶性黑色素瘤中的DNA指数和S期分数
Br J Ophthalmol. 1995 Jun;79(6):521-6. doi: 10.1136/bjo.79.6.521.